Of the nearly 68 million people with an STD in 2018, 26 million were newly diagnosed.
More key study findings:
- Young people between the ages of 15 and 24 accounted for nearly half of all new STIs in 2018.
- An estimated $16 billion in lifetime medical costs from STDs were acquired in 2018, most of which were attributed to sexually acquired HIV infections.
- Overall, women carried a disproportionate burden of severe STD outcomes and medical costs.
“At a time when [sexually transmitted infections] are at an all-time high, they have fallen out of the national conversation,” said Jonathan Mermin, MD, director of the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB prevention. “There is an urgent need to reverse the trend of STIs, especially in the wake of the COVID-19 pandemic, which has affected many STI prevention services.”
The report suggests the same strategies being used to address the challenges associated with the COVID-19 pandemic, such as express clinics with walk-in testing and partnerships with pharmacies and retail health clinics, could expand access to sexual healthcare.
More articles on public health:
US aims to vaccinate 1.5 million daily; Brazil variant found in Minnesota — 5 COVID-19 updates
COVID-19 death rates by state: Jan. 26
21 states where COVID-19 is spreading fastest, slowest: Jan. 26
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
